Back to search results
NCT05444751

GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries

Enrolling by Invitation
PHASE3Ages 18–80InterventionalTreatment
Hospital for Special Surgery, New York
~142 participants
Updated 2026-04-28 on ClinicalTrials.gov
What's tested:General anestheticSA + ESP

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
QoR15 survey scores
Measured over The QoR15 survey will be assessed preoperatively (in holding area). It will be assessed again immediately after surgery in the PACU and then at 2-weeks postoperatively at the patient's first follow-up visits

Conditions

Lumbar Disc Herniation
Lumbar Disc Disease
Lumbar Radiculopathy

Explore related trials

Intervertebral Disc Degenerative DisorderLumbar Disc DiseaseLumbar radiculopathyLumbar sprainProlapsed lumbar intervertebral disc

NCT05444751

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Hospital for Special Surgery

    New York, New Yorkno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients from the ages 18- 80 years
Patients with one or two-level microdiscectomy, laminotomy, or foraminotomy - prior spine surgery is allowed only if surgery was preformed at other levels.
Able to follow study protocol
Able to provide informed consent

Exclusion

Surgery with planned need for postoperative surgical drain.
Allergies of contraindication to any study anesthetic or analgesic medications.
Morbid obesity, defined as BMI \> 35 kg/m2.
Involved in the study of another investigational product that may affect the outcome.

What this trial measures

  • QoR15 survey scoresThe QoR15 survey will be assessed preoperatively (in holding area). It will be assessed again immediately after surgery in the PACU and then at 2-weeks postoperatively at the patient's first follow-up visits

    The primary outcome is the difference in the quality of recovery-15 (QoR15) score between the groups at each timepoint (before surgery, after surgery, and at their first 2 week follow-up visit). For this survey, a high number represents something that occurs often, while a low number indicates something that rarely or never occurs. Depending on the category/question asked, this may be good or bad. The questions on the survey will be split and compared so that for one subset of questions a high number is good while the opposite is true for the other subset of questions. This will be done so the comparison between groups is more accurate and meaningful.